Organisation paid for research Program year 2025 Source: CMS Open Payments

3Sync Research

Neither a doctor nor a teaching hospital

Research payments

$280,998

11 payments

Through program year 2025, 3Sync Research is reported as receiving $280,998 in research payments, across 11 payments.

By program year

2 rows
Year Kind Amount Payments
2025 Research $57,519 8
2024 Research $223,479 3

Breakdown

Who paid Research payments · program years 2024–2025
  1. Biogen, Inc. $223,479 3 payments
  2. GlaxoSmithKline, LLC. $57,519 8 payments
Studies the money was for Research payments · program years 2024–2025
  1. A Phase 2 Study of RTA 901 in Patients With Diabetic Peripheral Neuropathic Pain (CYPRESS) (CYPRESS) $223,479 3 payments
  2. A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Dose Find $57,519 8 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record